Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Sebastian Kobold, Stanislav Pantelyushin, Felicitas Rataj, Johannes vom Berg

Journal title: Frontiers in Oncology

Journal number: 8

Journal publisher: Frontiers Media S. A.

Published year: 2018

DOI identifier: 10.3389/fonc.2018.00285

ISSN: 2234-943X